search
Back to results

Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain

Primary Purpose

Acute Pain, Chronic Pain, Widespread, Schizophrenia

Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Ketamine
Placebo
Sponsored by
Hospital de Clinicas de Porto Alegre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Pain focused on measuring Ketamine, ERP, Oddball

Eligibility Criteria

18 Years - 40 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • male healthy subjects with higher education level

Exclusion Criteria:

  • do not understand Portuguese language
  • obese patients (BMI > 27 kg/m2)
  • use of NSAID, steroids, analgesics, anticonvulsant drugs, as well as alpha and beta-blockers
  • score ≥ 13 on Beck II Questionnaire
  • sleep deprivation in the night before evaluation

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    Group S-Ketamine

    Group Placebo

    Arm Description

    S-Ketamine will be diluted in normal saline and administrated in a target controlled infusion using an infusion pump to obtain a plasma target of 60 ng/ml according to Domino's model. Infusion will start during the interval between the 3rd and 4th blocks of the task.

    A previously prepared identical solution containing only normal saline will be infused at the same infusion rates of group ketamine.

    Outcomes

    Primary Outcome Measures

    AUC of the grand averaged mean differences between ERPs elicited by target and non-target words
    EEG will be recorded during all task time. The main outcome will be the area under de curve (AUC) of the grand averaged mean differences between event-related potencials (ERPs) elicited by target and non-target words at 100-200, 300-500 and 800-900 ms after stimulus presentation for parietal electrophysiological signal (Pz). The ERPs represent the averaged voltage of several trials.

    Secondary Outcome Measures

    Word ratings related to the semantic valence
    After viewing each word, volunteers were asked to classify them according to the semantic valence in the following categories: "positive," "negative" or "neutral."
    Response times (behavioural oddball data)
    Response times to word classification in oddball task

    Full Information

    First Posted
    April 12, 2019
    Last Updated
    April 15, 2019
    Sponsor
    Hospital de Clinicas de Porto Alegre
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03915938
    Brief Title
    Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain
    Official Title
    Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: a Placebo-controlled Study in Healthy Male Subjects
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2018
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2, 2017 (Actual)
    Primary Completion Date
    November 30, 2017 (Actual)
    Study Completion Date
    November 30, 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Hospital de Clinicas de Porto Alegre

    4. Oversight

    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This is a clinical trial that intend to determine the effects of S-ketamine on event-related potentials associated with semantic affective pain-processing
    Detailed Description
    Ketamine is a unique anesthetic with neural effects that are distinct from more commonly-used γ-aminobutyric acid agonists. Evidence suggest that analgesic effect of ketamine is primarily related to the affective than the sensorial aspects of pain interpretation. The investigators investigated whether ketamine, a noncompetitive NMDA antagonist, would modify the perceived emotional valence of pain-related words when compared to non-pain-related ones in healthy volunteers. Using a single session double-blind parallel placebo-controlled design, 24 healthy volunteers were randomized to receive intravenous S-ketamine (n=12) or placebo (n=12). During infusion (plasmatic target of 60 ng/ml), the effects of ketamine were recorded using EEG and oddball behavioral data was monitored. Evoked potentials (N200 and P300 components) were recorded during performance of a semantic written word oddball task containing pain-related (targets) and non-pain-related words (standards). Expected results: The findings of this study can help in the understanding of neurophysiologic mechanisms involved in ketamine's effects both in psychiatric diseases as in the treatment of postoperative acute and chronic pain.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Acute Pain, Chronic Pain, Widespread, Schizophrenia
    Keywords
    Ketamine, ERP, Oddball

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 2, Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    24 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Group S-Ketamine
    Arm Type
    Experimental
    Arm Description
    S-Ketamine will be diluted in normal saline and administrated in a target controlled infusion using an infusion pump to obtain a plasma target of 60 ng/ml according to Domino's model. Infusion will start during the interval between the 3rd and 4th blocks of the task.
    Arm Title
    Group Placebo
    Arm Type
    Placebo Comparator
    Arm Description
    A previously prepared identical solution containing only normal saline will be infused at the same infusion rates of group ketamine.
    Intervention Type
    Drug
    Intervention Name(s)
    Ketamine
    Intervention Description
    S-ketamine will be administered in precalculated infusion rates to obtain a plasmatic level of 60 ng/ml
    Intervention Type
    Drug
    Intervention Name(s)
    Placebo
    Intervention Description
    Administered in an identical way than ketamine.
    Primary Outcome Measure Information:
    Title
    AUC of the grand averaged mean differences between ERPs elicited by target and non-target words
    Description
    EEG will be recorded during all task time. The main outcome will be the area under de curve (AUC) of the grand averaged mean differences between event-related potencials (ERPs) elicited by target and non-target words at 100-200, 300-500 and 800-900 ms after stimulus presentation for parietal electrophysiological signal (Pz). The ERPs represent the averaged voltage of several trials.
    Time Frame
    up to 60 min
    Secondary Outcome Measure Information:
    Title
    Word ratings related to the semantic valence
    Description
    After viewing each word, volunteers were asked to classify them according to the semantic valence in the following categories: "positive," "negative" or "neutral."
    Time Frame
    up to 60 min
    Title
    Response times (behavioural oddball data)
    Description
    Response times to word classification in oddball task
    Time Frame
    up to 60 min
    Other Pre-specified Outcome Measures:
    Title
    Subjective euphoria rating
    Description
    Euphoria will be rated using an analogue visual scale ranging of 0 to 10.
    Time Frame
    up to 60 min
    Title
    Subjective sedation rating
    Description
    Sedation will be rated using an analogue visual scale ranging of 0 (completely awake) to 100 (sleeping).
    Time Frame
    up to 60 min

    10. Eligibility

    Sex
    Male
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    40 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: male healthy subjects with higher education level Exclusion Criteria: do not understand Portuguese language obese patients (BMI > 27 kg/m2) use of NSAID, steroids, analgesics, anticonvulsant drugs, as well as alpha and beta-blockers score ≥ 13 on Beck II Questionnaire sleep deprivation in the night before evaluation
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Wolnei Caumo, MD, PhD
    Organizational Affiliation
    Hospital de Clínicas de Porto Alegre
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided
    Citations:
    PubMed Identifier
    31611759
    Citation
    Schwertner A, Zortea M, Torres FV, Ramalho L, Alves CFDS, Lannig G, Torres ILS, Fregni F, Gauer G, Caumo W. S-Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals. Front Neurosci. 2019 Sep 13;13:959. doi: 10.3389/fnins.2019.00959. eCollection 2019.
    Results Reference
    derived

    Learn more about this trial

    Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain

    We'll reach out to this number within 24 hrs